Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic
stenosis and is the treatment of choice for patients at prohibitive and high surgical risk …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

Aims Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients
with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter …

Objectives: The aim of this study was to assess mortality and rehospitalization in patients
with new bundle branch block (BBB) and/or permanent pacemaker (PPM) after transcatheter …

Background Monitoring of microbiological cause of infective endocarditis (IE) remains key in
the understanding of IE; however, data from large, unselected cohorts are sparse. We aimed …

Introduction: Transcatheter aortic valve replacement (TAVR) has emerged as an effective
minimally-invasive alternative to surgical valve replacement in medium-to high-risk, elderly …

Objective To define the incidence and risk factors for infective endocarditis (IE) following
surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) …

Over the last 15 years, the management of aortic valve disease has been changed by
transcatheter aortic valve replacement, which has become the standard of care across the …

Objectives The aim of this study was to compare transcatheter aortic valve replacement
(TAVR) with the Acurate neo (NEO) and Evolut PRO (PRO) devices. Background The NEO …

The performance of transcatheter aortic valve replacement has expanded considerably
during the past decade. Technological advances and refinement in implantation techniques …